
HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL
Description
About HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL
The Human herpesvirus 6 (HHV6) B (strain Z29) Uncharacterized protein U90 Peptide (IEDB: 237892) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Uncharacterized protein Peptide, H-QFVSCYAKMLSGKNL-OH (Uniprot: Q77PU6 aa: 169-183) from JPT is produced under strict quality control and quality management.
HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL - Specifications
- Peptide sequence: H-QFVSCYAKMLSGKNL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Herpes
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL
References:
Read References with JPT’s Antigen Peptides
HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL has been described in:
Human herpesvirus 6B immediate-early I protein contains functional HLA-A*02, HLA-A*03, and HLA-B*07 class I restricted CD8(+) T-cell epitopes., Eur J Immunol, 2014 (PMID: 25243920)
DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen., Eur J Immunol, 2011 (PMID: 21604260)
Documentation
Documentation for HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL
Properties
Properties of HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Herpes |
Layout: | Freeze-dried in glass vial |
Organism: | Human herpesvirus 6 (HHV6) |
Protein Name: | Uncharacterized protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HHV 6B (strain Z29) Protein U90 169-183, QFVSCYAKMLSGKNL
Information | Values |
---|---|
Sequence: | H-QFVSCYAKMLSGKNL-OH |
Specifications: | 15mer peptide as TFA salt |